Fourth quarter and full year results 2009 - 28 January 2010

Title Dur Video
Interview in full 15:45 Play
Results 2:21 Play
R&D changes 3:06 Play
Restructuring programme 1:14 Play
Strategy 4:09 Play
Drug portfolio 2:28 Play
Outlook 2:27 Play

  • Now playing the interview with
    David Brennan, CEO

    "comment 1"